Skip to main content
. 2020 Feb 21;2020:8797683. doi: 10.1155/2020/8797683

Figure 3.

Figure 3

The percentage of Th17 cells in peripheral blood (a) and peritoneal fluid (b) of patients with ovarian cancer and in the group with benign ovarian tumor.